AU762826B2 - Orally administrable solid ribavirin dosage forms and process for making them - Google Patents

Orally administrable solid ribavirin dosage forms and process for making them Download PDF

Info

Publication number
AU762826B2
AU762826B2 AU21991/99A AU2199199A AU762826B2 AU 762826 B2 AU762826 B2 AU 762826B2 AU 21991/99 A AU21991/99 A AU 21991/99A AU 2199199 A AU2199199 A AU 2199199A AU 762826 B2 AU762826 B2 AU 762826B2
Authority
AU
Australia
Prior art keywords
ribavirin
composition
polymorphic forms
substantially free
compacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21991/99A
Other languages
English (en)
Other versions
AU2199199A (en
Inventor
Frank E. Bowen
Imtiaz A. Chaudry
Stephen M Liebowitz
Elliot I. Stupak
Winston A. Vadino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU762826(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU21991/99A priority Critical patent/AU762826B2/en
Publication of AU2199199A publication Critical patent/AU2199199A/en
Priority to AU16683/01A priority patent/AU742943B2/en
Application granted granted Critical
Publication of AU762826B2 publication Critical patent/AU762826B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21991/99A 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them Ceased AU762826B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU21991/99A AU762826B2 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them
AU16683/01A AU742943B2 (en) 1997-12-22 2001-01-29 Orally administrable solid ribavirin dosage forms and process for making them

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/997169 1997-12-22
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
US08/997172 1997-12-22
AU21991/99A AU762826B2 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU16683/01A Division AU742943B2 (en) 1997-12-22 2001-01-29 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
AU2199199A AU2199199A (en) 1999-07-12
AU762826B2 true AU762826B2 (en) 2003-07-03

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21991/99A Ceased AU762826B2 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Country Status (26)

Country Link
US (3) US6337090B1 (https=)
EP (2) EP1321147A1 (https=)
JP (2) JP2001526234A (https=)
KR (1) KR100575389B1 (https=)
CN (1) CN1155388C (https=)
AR (1) AR008977A1 (https=)
AT (1) ATE234103T1 (https=)
AU (1) AU762826B2 (https=)
BR (1) BR9814367A (https=)
CA (4) CA2365412C (https=)
CO (1) CO4970774A1 (https=)
DE (1) DE69812094T2 (https=)
DK (1) DK0991415T3 (https=)
ES (1) ES2191987T3 (https=)
HU (1) HUP0100433A3 (https=)
IL (1) IL136549A (https=)
MY (1) MY119656A (https=)
NO (1) NO20003234L (https=)
NZ (1) NZ504994A (https=)
PE (1) PE20000066A1 (https=)
PL (1) PL190267B1 (https=)
PT (1) PT991415E (https=)
SK (1) SK284520B6 (https=)
TW (1) TW575436B (https=)
WO (1) WO1999032128A1 (https=)
ZA (1) ZA9811726B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
DE60134391D1 (de) * 2000-03-06 2008-07-24 Salient Surgical Technologies Flüssigkeitsabgabesystem und steuerung für elektrochirurgische geräte
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
EP1443911A1 (en) * 2001-11-02 2004-08-11 Geneva Pharmaceuticals, Inc. Process for preparing quick dissolving, high loading ribavirin compositions
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
RU2005133093A (ru) * 2003-03-28 2006-07-27 Фармассет, Инк. (Us) Соединения для лечения флавивирусных инфекций
TR200701424T1 (tr) * 2004-09-09 2007-04-24 Bayer Healthcare Ag Suda çözünebilen katı dozaj formunda farmasötik bileşim.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
JP5694643B2 (ja) * 2005-08-05 2015-04-01 スリーエム イノベイティブ プロパティズ カンパニー 改善された流動性を示す組成物
US20080131398A1 (en) * 2006-08-21 2008-06-05 United Therapeutics Corporation Combination therapy for treatment of viral infections
US9072664B2 (en) * 2008-05-22 2015-07-07 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
US9956170B2 (en) * 2008-06-26 2018-05-01 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
EP2309984B1 (en) * 2008-07-02 2018-04-11 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211711A (en) * 1977-08-06 1980-07-08 Dynamit Nobel Aktiengesellschaft Method of preparing phthalide
CA2135669A1 (en) * 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
EP0625158B1 (en) * 1992-01-06 1999-03-31 The Wellcome Foundation Limited Therapeutic nucleosides of the 2',3'-dideoxy-3'-fluoro-purine series
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211711A (en) * 1977-08-06 1980-07-08 Dynamit Nobel Aktiengesellschaft Method of preparing phthalide
CA2135669A1 (en) * 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent

Also Published As

Publication number Publication date
MY119656A (en) 2005-06-30
PE20000066A1 (es) 2000-02-09
CN1155388C (zh) 2004-06-30
PT991415E (pt) 2003-06-30
SK8942000A3 (en) 2001-04-09
CA2365412A1 (en) 1999-07-01
CA2300452A1 (en) 1999-07-01
CA2365412C (en) 2002-09-17
CO4970774A1 (es) 2000-11-07
DE69812094T2 (de) 2003-12-24
CA2323849C (en) 2002-06-11
EP1321147A1 (en) 2003-06-25
JP2006083189A (ja) 2006-03-30
DE69812094D1 (de) 2003-04-17
BR9814367A (pt) 2000-10-17
IL136549A0 (en) 2001-06-14
CA2287056A1 (en) 1999-07-01
IL136549A (en) 2005-05-17
PL190267B1 (pl) 2005-11-30
AR008977A1 (es) 2000-03-08
HUP0100433A2 (hu) 2001-12-28
KR20010033441A (ko) 2001-04-25
US6051252A (en) 2000-04-18
EP0991415B1 (en) 2003-03-12
US6337090B1 (en) 2002-01-08
NO20003234L (no) 2000-08-21
ES2191987T3 (es) 2003-09-16
CA2300452C (en) 2000-11-28
EP0991415A1 (en) 2000-04-12
ZA9811726B (en) 1999-06-21
SK284520B6 (sk) 2005-05-05
NZ504994A (en) 2002-10-25
CA2323849A1 (en) 1999-07-01
KR100575389B1 (ko) 2006-05-03
JP2001526234A (ja) 2001-12-18
ATE234103T1 (de) 2003-03-15
WO1999032128A1 (en) 1999-07-01
DK0991415T3 (da) 2003-06-16
HK1034674A1 (en) 2001-11-02
AU2199199A (en) 1999-07-12
PL341230A1 (en) 2001-03-26
CA2287056C (en) 2000-08-15
NO20003234D0 (no) 2000-06-21
TW575436B (en) 2004-02-11
US6335032B1 (en) 2002-01-01
CN1283117A (zh) 2001-02-07
HUP0100433A3 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
AU762826B2 (en) Orally administrable solid ribavirin dosage forms and process for making them
KR100634253B1 (ko) 초강력 붕해제를 사용한 고속-용해 에파비렌즈 캡슐 또는정제 및 그의 제조 방법
JP6574477B2 (ja) ルカパリブの高投与力価錠剤
KR100202154B1 (ko) 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제
JPS59101423A (ja) 新規なニフエジピン固形製剤
US5914128A (en) Orally administrable solid dosage form
HU224983B1 (en) Swallow tablet comprising paracetamol
US5916594A (en) Process of making solid ribavirin dosage forms
AU742943B2 (en) Orally administrable solid ribavirin dosage forms and process for making them
EP0642786B1 (en) Method for the manufacture of a laxative composition
MXPA00006188A (en) Orally administrable solid ribavirin dosage forms and process for making them
JPH0141125B2 (https=)
CZ20002303A3 (cs) Perorálně podávatelné pevné ribavirinové dávkové formy a způsob jejich přípravy
KR20240093577A (ko) 약학적 조성물
CA3000186A1 (en) Stable formulations of fingolimod
CZ296045B6 (cs) Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
CN108721241A (zh) 一种包含缬沙坦和氨氯地平的固体组合物及其制备方法
WO2004058152A2 (en) An extended release pharmaceutical composition of phenytoin sodium
HK1034674B (en) Orally administrable solid ribavirin dosage forms and process for making them
KR20050010843A (ko) 활성 성분을 지속 방출시키는, 옥스카바제핀 함유약제학적 조성물

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)